Author： Girard D.Z.
Publisher： Adis International
ISSN： 1174-5878
Source： Pediatric Drugs, Vol.4, Iss.5, 2002-01, pp. : 299-313
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Which vaccination strategy for Africa's meningitis belt?
Inpharma, Vol. 1, Iss. 1220, 2000-01 ,pp. :
Access to resources
Recommend
Which varicella vaccination strategy worth it in Italy?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. :
Which Dutch meningococcal group C vaccination programme?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
Hypotonic-Hyporesponsive Episodes Following Pertussis Vaccination: A Cause for Concern?
By Gold M.S.
Drug Safety, Vol. 25, Iss. 2, 2002-01 ,pp. :
Preventing CMV infection - which strategy's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :